These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9259836)

  • 1. Post-transfusion hepatitis C in Finland.
    Ebeling F; Naukkarinen R; Leikola J
    Transfus Med; 1991 Jun; 1(2):109-13. PubMed ID: 9259836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transfusion hepatitis revisited.
    Ismay SL; Thomas S; Fellows A; Keller A; Kenrick KG; Archer GT; Wylie BR; Cossart YE
    Med J Aust; 1995 Jul; 163(2):74-7. PubMed ID: 7542359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectivity of blood seropositive for hepatitis C virus antibodies.
    van der Poel CL; Reesink HW; Schaasberg W; Leentvaar-Kuypers A; Bakker E; Exel-Oehlers PJ; Lelie PN
    Lancet; 1990 Mar; 335(8689):558-60. PubMed ID: 1968574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transfusion hepatitis after open-heart surgery in Finland--a prospective study.
    Ebeling F; Naukkarinen R; Hanhela R; Jalonen J; Kaukinen L; Salmenperä M; Suistomaa M; Leikola J
    Transfus Med; 1991 Jun; 1(2):103-7. PubMed ID: 9259835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
    Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
    Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.
    Van der Poel CL; Cuypers HT; Reesink HW; Weiner AJ; Quan S; Di Nello R; Van Boven JJ; Winkel I; Mulder-Folkerts D; Exel-Oehlers PJ
    Lancet; 1991 Feb; 337(8737):317-9. PubMed ID: 1671231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of HCV infection by RIBA indeterminate and positive blood units.
    Kolho E; Naukkarinen R; Krusius T
    Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-A, non-B hepatitis and the anti-HCV assay.
    Barbara JA; Contreras M
    Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
    Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
    Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis.
    Larsen J; Skaug K; Maeland A; Hetland G; Stoervold G
    Transfus Med; 1991 Mar; 1(1):13-6. PubMed ID: 9259821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients.
    Busch MP
    Transfus Clin Biol; 2001 Jun; 8(3):200-6. PubMed ID: 11499958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay.
    Lai ME; De Virgilis S; Argiolu F; Farci P; Mazzoleni AP; Lisci V; Rapicetta M; Clemente MG; Nurchis P; Arnone M
    J Pediatr Gastroenterol Nutr; 1993 May; 16(4):458-64. PubMed ID: 7686220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reduction of the post-transfusion hepatitis C risk in patients undergoing bone marrow allograft].
    Norol F; Roche B; Saint Marc Girardin MF; Kuentz M; Desforges L; Cordonnier C; Duedari N; Vernant JP
    Rev Fr Transfus Hemobiol; 1993 Dec; 36(6):499-507. PubMed ID: 7509605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that use of a second-generation hepatitis C antibody assay prevents additional cases of transfusion-transmitted hepatitis.
    Aoki SK; Kuramoto IK; Anderson S; Schoening V; Rodriguez R; Fernando L; Sazama K; Holland PV
    J Viral Hepat; 1994; 1(1):73-7. PubMed ID: 8790562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.